Infectious Diseases

Intrexon is currently working with collaborators on target indications for infectious diseases that may include treatment of bacterial infections associated with acute and chronic wounds, the treatment of acute and chronic Pseudomonas aeruginosa lung infections, and the treatment of infections of Clostridium difficile. Additionally Intrexon through collaboration is developing new bacteriophage-based therapies to target specific antibiotic resistant infections; lantibiotics represent a novel class of broad-spectrum antibiotics for the treatment of infectious diseases in humans and companion animals.